Background
 Quantitative testing of hepatitis B surface antigen (qHBsAg) in conjunction with HBV DNA testing may be useful in chronic HBV disease management. [1] [2] [3]  qHBsAg testing also provides information for clinicians to monitor patient responses to antiviral therapy. Conclusions  These results demonstrate the potential clinical utility of the Quest qHBsAg assay: high sensitivity, high NPV, and the ability to detect qHBsAg in patients with undetectable HBV DNA.

The lower median level of HBsAg for the HBV DNA-negative group may indicate treatment-induced suppression of viral replication.
The qHBsAg assay provides a viral-independent prognostic analyte for clinicians to follow prospectively after initiating treatment.
a Data updated since abstract acceptance, as reflected in the conference poster.
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